All Articles
402 analyses · page 9 of 17
- Industry95% never get the right treatment: the IOCDF OCD care-crisis report and what it means for parity in 2026
- IndustryAASM 2025: when CBT-I meets a sleeping pill, the pill is the one that loses
- ResearchFamily-Based CBT Beats Active Control in Paediatric OCD — But the Margin Is Smaller Than We Like to Say
- ResearchBipolar II maintenance: the evidence base for lithium and lamotrigine is thinner than the guidelines suggest
- ResourceBTTI 2026: Where Clinicians Actually Learn to Run ERP for OCD
- ToolWAI-SR + TFI Cohesiveness in telehealth groups: a minimal two-scale process kit
- ResearchOne Question About Suicidality, 9.5 Years of Mortality: What a Korean National Cohort Tells Us
- ResearchOne Dose of LSD for Generalised Anxiety: What the JAMA Phase 2b Actually Showed
- ToolPBS-5: a five-item screen for non-substance addictive behaviours, anchored to ICD-11
- ResourceCIIS Psychedelic-Assisted Therapies Certificate: 2026-2027 Cohort Now Open
- IndustryAustralia's Authorised Prescriber Scheme: What 134 Patients Reveal About a Real-World Psychedelic Programme
- IndustryIndia's Tele-MANAS at year three: 3.4 million calls, 53 cells, and the unfinished business of the treatment gap
- ResearchA System Fix, Not a Therapist Fix: How Mozambique Closed Its MNS Care Gaps by 46 Points
- ToolThe ETMCQ-R: 18 Items to Know Whether Your Patient Can Actually Learn from You
- IndustryCMS 2026 Fee Schedule: Solo Therapists Get a Flat Rate, Integrated Practices Get +3.77%
- IndustryRussia's Mental Health System Redraws Its Boundaries: Two 2026 Orders That Every Practitioner Needs to Know
- ResearchTherapeutic Alliance With an AI Chatbot Predicts Outcomes the Same Way It Does With Humans
- ResourceThe Bowlby Centre's Attachment Certificate: A Year of Saturdays That Pays Off
- IndustryRejoyn at 24 months — what the first FDA-authorised prescription DTx for depression actually did to the market
- ToolPassive smartphone sensing as a between-session clinical instrument
- ResearchCluster-C Personality Disorders Cost €27K–€60K Per Patient Per Year — and We Keep Overlooking Them
- ResourceInternal Family Systems Level 1 in 2026 — the training track that is not CBT or EMDR
- IndustryAnxiety and Trauma Disorders Nearly Doubled Among US Older Adults in a Decade — State System Data, n=4.2M
- ResearchAmygdala neurofeedback for PTSD moves from trial into community clinic